No significant associations were found between Siglec15 expression and clinicopathological characteristics, such as age, gender, tumor location, TNM stage, MMR status, and tumor growth pattern, excluding that Siglec15(SA) was correlated with age (p<0.05) (Table 1). Here, SIGLEC15 is linked to neoplasm.